Back
Traws Pharma Stock Price Chart

Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
45
TRAW
Traws Pharma
Last Price:
$1.71
Seasonality Move:
-15.9%
7 Day Trial
ALL ACCESS PASS
$
7

Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
The current trend is relatively stagnant and TRAW is experiencing slight buying pressure.
Traws Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.51 | Sell |
20-day SMA: | 1.36 | Buy |
50-day SMA: | 1.65 | Sell |
200-day SMA: | 4.95 | Sell |
8-day EMA: | 1.52 | Sell |
20-day EMA: | 1.47 | Buy |
50-day EMA: | 1.91 | Sell |
200-day EMA: | 5.43 | Sell |
Traws Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 48.73 | Sell |
Chaikin Money Flow: | -593274 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Traws Pharma Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Traws Pharma Stock
Is Traws Pharma Stock a Buy?
-
Traws Pharma share price is 1.48 while TRAW 8-day simple moving average is 1.51, which is a Sell signal.
-
The stock price of TRAW is 1.48 while Traws Pharma 20-day SMA is 1.36, which makes it a Buy.
-
Traws Pharma 50-day simple moving average is 1.65 while TRAW share price is 1.48, making it a Sell technically.
-
TRAW stock price is 1.48 and Traws Pharma 200-day simple moving average is 4.95, creating a Sell signal.
TRAW Technical Analysis vs Fundamental Analysis
Sell
45
Traws Pharma (TRAW)
is a Sell
Is Traws Pharma a Buy or a Sell?
-
Traws Pharma stock is rated a SellThe current Traws Pharma [TRAW] share price is $1.48. The Score for TRAW is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Traws Pharma Stock Info
Market Cap:
8.2M
Price in USD:
1.48
Share Volume:
593.3K
Traws Pharma 52-Week Range
52-Week High:
19.44
52-Week Low:
0.97
Sell
45
Traws Pharma (TRAW)
is a Sell
Traws Pharma Share Price Forecast
-
What is the Traws Pharma stock price today?The Traws Pharma stock price is 1.48 USD today.
-
Will TRAW stock go up or go down?Traws Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Traws Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Traws Pharma is overvalued.
Is Traws Pharma Stock a Buy?
-
Traws Pharma share price is 1.48 while TRAW 8-day exponential moving average is 1.52, which is a Sell signal.
-
The stock price of TRAW is 1.48 while Traws Pharma 20-day EMA is 1.47, which makes it a Buy.
-
Traws Pharma 50-day exponential moving average is 1.91 while TRAW share price is 1.48, making it a Sell technically.
-
TRAW stock price is 1.48 and Traws Pharma 200-day simple moving average is 5.43, creating a Sell signal.
Technical Analysis of Traws Pharma
Should I short Traws Pharma stock?
-
TRAW Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Traws Pharma is a Sell
-
Traws Pharma Relative Strength Index (RSI) is 48.73, which suggest Traws Pharma is oversold
-
The Bollinger Bands (25) for Traws Pharma is ( - ), which suggest Traws Pharma is a Buy
-
The Bollinger Bands (100) for Traws Pharma is ( - ), which suggest Traws Pharma is a Buy
* Traws Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.